Opinions Gordon Reid
Teladoc IncTDOCDON'T BUYAug 27, 2020
Gordon ReidUnknown
$213.12
Stock price when the opinion was issued
$7.05
As of Jun 05, 2026. Market Open.
Healthcare
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
You might be interested:
DON'T BUY
;fill-opacity:1;'/%3e%3cpath%20d='M31%2018.6001V30H8V18.6001L14.1334%2022.4334L19.4999%2014L24.8669%2022.4334L31%2018.6001Z'%20fill='%23EE5432'%20style='fill:%23EE5432;fill:color(display-p3%200.9340%200.3310%200.1956);fill-opacity:1;'/%3e%3c/svg%3e){kind=small}
Premium contentTOP PICK
Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in whole-person virtual care, Teladoc Health uses proprietary health signals and personalized interactions to drive better health outcomes across the full continuum of care, at every stage in a person’s health journey. Social media mentions are up 19% in the past 24h.
DON'T BUY
TDOC vs. QQQ vs. SOXX QQQ and SOXX, he has no idea where the market's going to be next month, next quarter, or this year. All he knows is that there's going to be a lot of volatility. So it's an environment of less investing, more trading. Have to be nimble, active. SOXX charts very well, it's the DOW modern day Transport Index, so you need to watch it. He was in TDOC a year ago, and backed away. Healthcare and biotech have had a difficult time.
Healthcare
DON'T BUY
He sold. Rough technically. A lot of money moved out of the pandemic names. Down 72%. Be careful, as he doesn't see the momentum changing right away. Need stronger earnings prints and better valuation for him. 5.5x price to sales, pretty expensive. Interest rates will be hard on those with strong revenue growth but no profit.
Healthcare
BUY ON WEAKNESS
SELL
Great story. World's largest platform for online healthcare. Price target of $161. Down 50% from all-time highs, puzzling. Intellectual property is very solid, so he's not sure if it's mismanaged. It all comes down to execution. He had a stop on it, and got out of the way. Investors should do the same.
Healthcare
Premium contentTOP PICK
HOLD
Rough ride. Acquisitions, growing pains, disappointing results. Future of these names continues to make sense. Be patient. Chart looks as though it's basing. Higher growth name, so hurt by threat of rising rates. A disruptor, long-term growth, we'll see ups and downs. Put your stop losses in place.
Stan WongOwned
Healthcare
Look for companies that are the future. The US has the most expensive healthcare as a percentage of GDP by a long shot. They have to get a handle on this, and one way is through a phone or video format. This company is a bit too risky, because they are focused on just this issue. He prefers CVS with their distribution network.